RESUMO
OBJECTIVE: To grasp the meaning of perinatal palliative care for the multidisciplinary team. METHODS: This is a qualitative study guided by content analysis. The study included 56 health professionals working in maternal and child units of a public university hospital. A semi-structured interview was conducted, which was recorded and subsequently fully transcribed. The collection took place from June 2018 to May 2019. Data were entered and exported to Atlas ti: The Qualitative Date Analysis & Research Software, version 23.1.1.0. RESULTS: Four thematic categories emerged from the data analysis: palliative care and eligible public in the view of professionals; communication between family and team in decision-making; assistance in palliative care; humanized care. CONCLUSIONS: The professionals think of palliative care in Perinatology in a similar way and perceive the difficulties of communication with the family and decision-making. They agree that it is necessary to provide greater support to the family, and to provide comfort measures, either for the non-viable fetus or for the baby eligible for palliative care.
Assuntos
Cuidados Paliativos , Equipe de Assistência ao Paciente , Assistência Perinatal , Pesquisa Qualitativa , Humanos , Cuidados Paliativos/psicologia , Feminino , Assistência Perinatal/métodos , Tomada de Decisões , Masculino , Adulto , Atitude do Pessoal de Saúde , Relações Profissional-Família , Recém-Nascido , Gravidez , Pessoa de Meia-Idade , Entrevistas como Assunto , ComunicaçãoRESUMO
Introduction: Chronic obstructive pulmonary disease is a systemic disease characterized not only by respiratory symptoms but also by physical deconditioning and muscle weakness. One prominent manifestation of this disease is the decline in respiratory muscle strength. Previous studies have linked the genotypes of insulin-like growth factor 1 and 2 (IGF-1 and IGF-2) to muscle weakness in other populations without this disease. However, there is a notable knowledge gap regarding the biological mechanisms underlying respiratory muscle weakness, particularly the role of IGF-1 and IGF-2 genotypes in this pulmonary disease. Therefore, this study aimed to investigate, for the first time, the association between IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with chronic obstructive pulmonary disease. In addition, we analyzed the relationship between oxidative stress, chronic inflammation, and vitamin D with respiratory muscle strength. Methods: A cross sectional study with 61 individuals with chronic obstructive pulmonary disease. Polymerase chain reaction of gene polymorphisms IGF-1 (rs35767) and IGF-2 (rs3213221) was analyzed. Other variables, related to oxidative stress, inflammation and Vitamin D were dosed from peripheral blood. Maximal inspiratory and expiratory pressure were measured. Results: The genetic polymorphisms were associated with respiratory muscle strength ( 3.0 and 3.5; = 0.57). Specific genotypes of IGF-1 and IGF-2 presented lower maximal inspiratory and expiratory pressure (<0.05 for all). Oxidative stress, inflammatory biomarkers, and vitamin D were not associated with respiratory muscle strength. Conclusion: The polymorphisms of IGF-1 and IGF-2 displayed stronger correlations with respiratory muscle strength compared to blood biomarkers in patients with chronic obstructive pulmonary disease. Specific genotypes of IGF-1 and IGF-2 were associated with reduced respiratory muscle strength in this population.
Introducción: La enfermedad pulmonar obstructiva crónica es una enfermedad sistémica caracterizada no solo por síntomas respiratorios, sino también por el deterioro físico y la debilidad muscular. Una manifestación destacada de esta enfermedad es el declive en la fuerza de los músculos respiratorios. Estudios previos han vinculado los genotipos de factor de crecimiento insulínico 1 y 2 (IGF-1 e IGF-2) con la debilidad muscular en poblaciones sin esta enfermedad. Sin embargo, existe un vacío de conocimiento con respecto a los mecanismos biológicos subyacentes a la debilidad de los músculos respiratorios, en particular el papel de los genotipos IGF-1 e IGF-2 en esta enfermedad pulmonar. Por lo tanto, este estudio tuvo como objetivo investigar, por primera vez, la asociación de los genotipos IGF-1 e IGF-2 con la fuerza de los músculos respiratorios en individuos con enfermedad pulmonar obstructiva crónica. Además, analizamos la relación entre el estrés oxidativo, la inflamación crónica y la vitamina D con la fuerza de los músculos respiratorios. Métodos: Un estudio transversal con 61 individuos con enfermedad pulmonar obstructiva crónica. Se analizó la reacción en cadena de la polimerasa de los polimorfismos genéticos IGF-1 (rs35767) e IGF-2 (rs3213221). Otras variables relacionadas con el estrés oxidativo, la inflamación y la vitamina D se dosificaron a partir de muestras de sangre periférica. Se midieron las presiones inspiratorias y espiratorias máximas. Resultados: Los polimorfismos genéticos están asociados con la fuerza de los músculos respiratorios (F: 3.0 y 3.5; R2= 0.57). Genotipos específicos de IGF-1 e IGF-2 presentaron bajos valores en las presiones inspiratorias y espiratorias (p<0.05 en todos los casos). El estrés oxidativo, los biomarcadores inflamatorios y la vitamina D no se asociaron con la fuerza de los músculos respiratorios. Conclusión: Los polimorfismos de IGF-1 e IGF-2 mostraron correlaciones más sólidas con la fuerza de los músculos respiratorios en pacientes con enfermedad pulmonar obstructiva crónica en comparación con los biomarcadores sanguíneos. Genotipos específicos de IGF-1 e IGF-2 se asociaron con una disminución de la fuerza de los músculos respiratorios en esta población.
Assuntos
Genótipo , Fator de Crescimento Insulin-Like II , Fator de Crescimento Insulin-Like I , Força Muscular , Estresse Oxidativo , Doença Pulmonar Obstrutiva Crônica , Músculos Respiratórios , Humanos , Estudos Transversais , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Doença Pulmonar Obstrutiva Crônica/genética , Força Muscular/fisiologia , Masculino , Fator de Crescimento Insulin-Like I/metabolismo , Músculos Respiratórios/fisiopatologia , Fator de Crescimento Insulin-Like II/genética , Fator de Crescimento Insulin-Like II/metabolismo , Idoso , Feminino , Pessoa de Meia-Idade , Inflamação/fisiopatologia , Inflamação/genética , Vitamina D/sangue , Debilidade Muscular/fisiopatologia , Debilidade Muscular/genéticaRESUMO
INTRODUCTION: Chronic obstructive pulmonary disease is a systemic disease characterized not only by respiratory symptoms but also by physical deconditioning and muscle weakness. One prominent manifestation of this disease is the decline in respiratory muscle strength. Previous studies have linked the genotypes of insulin-like growth factor 1 and 2 (IGF-1 and IGF-2) to muscle weakness in other populations without this disease. However, there is a notable knowledge gap regarding the biological mechanisms underlying respiratory muscle weakness, particularly the role of IGF-1 and IGF-2 genotypes in this pulmonary disease. Therefore, this study aimed to investigate, for the first time, the association between IGF-1 and IGF-2 genotypes with respiratory muscle strength in individuals with chronic obstructive pulmonary disease. In addition, we analyzed the relationship between oxidative stress, chronic inflammation, and vitamin D with respiratory muscle strength. METHODS: A cross sectional study with 61 individuals with chronic obstructive pulmonary disease. Polymerase chain reaction of gene polymorphisms IGF-1 (rs35767) and IGF-2 (rs3213221) was analyzed. Other variables, related to oxidative stress, inflammation and Vitamin D were dosed from peripheral blood. Maximal inspiratory and expiratory pressure were measured. RESULTS: The genetic polymorphisms were associated with respiratory muscle strength ( 3.0 and 3.5; = 0.57). Specific genotypes of IGF-1 and IGF-2 presented lower maximal inspiratory and expiratory pressure (<0.05 for all). Oxidative stress, inflammatory biomarkers, and vitamin D were not associated with respiratory muscle strength. CONCLUSION: The polymorphisms of IGF-1 and IGF-2 displayed stronger correlations with respiratory muscle strength compared to blood biomarkers in patients with chronic obstructive pulmonary disease. Specific genotypes of IGF-1 and IGF-2 were associated with reduced respiratory muscle strength in this population.
INTRODUCCIÓN: La enfermedad pulmonar obstructiva crónica es una enfermedad sistémica caracterizada no solo por síntomas respiratorios, sino también por el deterioro físico y la debilidad muscular. Una manifestación destacada de esta enfermedad es el declive en la fuerza de los músculos respiratorios. Estudios previos han vinculado los genotipos de factor de crecimiento insulínico 1 y 2 (IGF-1 e IGF-2) con la debilidad muscular en poblaciones sin esta enfermedad. Sin embargo, existe un vacío de conocimiento con respecto a los mecanismos biológicos subyacentes a la debilidad de los músculos respiratorios, en particular el papel de los genotipos IGF-1 e IGF-2 en esta enfermedad pulmonar. Por lo tanto, este estudio tuvo como objetivo investigar, por primera vez, la asociación de los genotipos IGF-1 e IGF-2 con la fuerza de los músculos respiratorios en individuos con enfermedad pulmonar obstructiva crónica. Además, analizamos la relación entre el estrés oxidativo, la inflamación crónica y la vitamina D con la fuerza de los músculos respiratorios. MÉTODOS: Un estudio transversal con 61 individuos con enfermedad pulmonar obstructiva crónica. Se analizó la reacción en cadena de la polimerasa de los polimorfismos genéticos IGF-1 (rs35767) e IGF-2 (rs3213221). Otras variables relacionadas con el estrés oxidativo, la inflamación y la vitamina D se dosificaron a partir de muestras de sangre periférica. Se midieron las presiones inspiratorias y espiratorias máximas. RESULTADOS: Los polimorfismos genéticos están asociados con la fuerza de los músculos respiratorios (F: 3.0 y 3.5; R2= 0.57). Genotipos específicos de IGF-1 e IGF-2 presentaron bajos valores en las presiones inspiratorias y espiratorias (p<0.05 en todos los casos). El estrés oxidativo, los biomarcadores inflamatorios y la vitamina D no se asociaron con la fuerza de los músculos respiratorios. CONCLUSIÓN: Los polimorfismos de IGF-1 e IGF-2 mostraron correlaciones más sólidas con la fuerza de los músculos respiratorios en pacientes con enfermedad pulmonar obstructiva crónica en comparación con los biomarcadores sanguíneos. Genotipos específicos de IGF-1 e IGF-2 se asociaron con una disminución de la fuerza de los músculos respiratorios en esta población.
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Músculos Respiratórios/fisiopatologia , Fator de Crescimento Insulin-Like I/metabolismo , Fator de Crescimento Insulin-Like II/genética , Fator de Crescimento Insulin-Like II/metabolismo , Estresse Oxidativo , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Doença Pulmonar Obstrutiva Crônica/genética , Força Muscular/fisiologia , Genótipo , Vitamina D/sangue , Estudos Transversais , Debilidade Muscular/fisiopatologia , Debilidade Muscular/genética , Inflamação/fisiopatologia , Inflamação/genéticaRESUMO
BACKGROUND: Despite the high prevalence of sleep disturbances in idiopathic pulmonary fibrosis (IPF), the relationship between physical activity in daily life (PADL) and sleep in this population remains unclear. OBJECTIVES: Investigate the impact of sleep on different domains of PADL in IPF and characterize their PADL profile. METHODS: Sixty-seven participants (thirty-three with IPF and thirty-four healthy subjects [control group]) were included. The subjects underwent assessments of pulmonary function, exercise capacity, respiratory and peripheral muscle strength, PADL, sleep, dyspnea, and health-related quality of life. PADL and sleep measures were assessed using an activity monitor (Actigraph®, wGT3x-BT). Associations between sleep and PADL were done using correlation and regression models. RESULTS: In the IPF, sleep duration at night associated significantly with step counts, sedentary, light, and moderate-to-vigorous physical activity (MVPA) (-0.82 ≤ R ≤ 0.43; p < .05 for all). Lung function and sleep partially explained PADL variables (0.19 ≤ R2 ≤ 0.65, p < .05 for all). Compared to controls, the IPF subjects presented lower step counts, less time spent in MVPA, standing position, and more time spent in lying position (p < .05, for all). CONCLUSIONS: Sleep duration is associated with PADL in IPF. The PADL profile of patients is worse than in control subjects.
Assuntos
Fibrose Pulmonar Idiopática , Qualidade de Vida , Humanos , Duração do Sono , Exercício Físico/fisiologia , PulmãoRESUMO
ABSTRACT Objective: To grasp the meaning of perinatal palliative care for the multidisciplinary team. Methods: This is a qualitative study guided by content analysis. The study included 56 health professionals working in maternal and child units of a public university hospital. A semi-structured interview was conducted, which was recorded and subsequently fully transcribed. The collection took place from June 2018 to May 2019. Data were entered and exported to Atlas ti: The Qualitative Date Analysis & Research Software, version 23.1.1.0. Results: Four thematic categories emerged from the data analysis: palliative care and eligible public in the view of professionals; communication between family and team in decision-making; assistance in palliative care; humanized care. Conclusions: The professionals think of palliative care in Perinatology in a similar way and perceive the difficulties of communication with the family and decision-making. They agree that it is necessary to provide greater support to the family, and to provide comfort measures, either for the non-viable fetus or for the baby eligible for palliative care.
RESUMO Objetivo: Apreender o significado dos cuidados paliativos perinatais para a equipe multiprofissional. Métodos: Trata-se de um estudo qualitativo orientado pela análise de conteúdo. Participaram do estudo 56 profissionais de saúde atuantes em unidades materno-infantis de um hospital universitário público. Foi realizada uma entrevista semiestruturada, a qual foi gravada e posteriormente transcrita na íntegra. A coleta ocorreu no período de junho de 2018 a maio de 2019. Os dados foram digitados e exportados para o software Atlas ti: The Qualitative Date Analysis & Research Software, versão 23.1.1.0. Resultados: Quatro categorias temáticas emergiram da análise dos dados: cuidados paliativos e público elegível na visão dos profissionais; comunicação entre família e equipe na tomada de decisão; assistência no cuidado paliativo; cuidado humanizado. Conclusões: Os profissionais significam os cuidados paliativos em perinatologia de modo semelhante e percebem as dificuldades de comunicação com a família e a tomada de decisão. Concordam que é necessário fornecer maior apoio à família e proporcionar medidas de conforto, seja para o feto inviável, seja para o bebê elegível para cuidados paliativos.
RESUMO
Objectives: To verify the prevalence of frailty in patients hospitalized with acute exacerbation of COPD; to compare two frailty assessment methods: Edmonton Scale and the Fried Frailty Phenotype, and to associate frailty with functioning in these patients. Methods: Patients hospitalized due to an acute exacerbation of COPD were included. The assessment of pulmonary function, frailty, and functioning was performed. Frailty assessment was performed by the Edmonton Scale and Fried Frailty Phenotype. Individuals were classified into "frail," "pre-frail" and "non-frail." Functioning was evaluated by the one sit-to-stand test. Results: Thirty-five individuals were included (17 male, 69 ± 9 years; FEV1/FVC 47 ± 10%; FEV1 34 (24-52) % predicted). Participants scored 3 (3-4) points on the Edmonton Scale and 7 (5-9) points on the Fried Frailty Phenotype. According to the Fried model, 17% were considered prefrail and 83% frail and in the Edmonton scale, 20% were classified as nonfrail, 29% prefrail, and 51% frail. There was a positive moderate correlation between the two methods (r = 0.42; p=0.011); however, there was no agreement between them (p=0.20). This probably occurs because they assess the same construct, i.e., frailty; however, they are different in their components. There was a negative and moderate correlation between the Fried Frailty Phenotype and functioning (r = -0.43; p=0.009). Conclusion: Most hospitalized individuals with exacerbated COPD with severe and very severe airflow limitation are frail and the assessment methods correlate, but there is no agreement. Additionally, there is association between frailty and functioning in this population.
RESUMO
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has affected the mental health, sleep and quality of life, especially in individuals with chronic disease. Therefore, the purpose of this systematic review and meta-analysis was to investigate the impact of the COVID-19 pandemic on neuropsychiatric disorders (depression, anxiety, stress), sleep disorders (sleep quality, insomnia) and quality of life in individuals with Parkinson's disease (PD), Multiple Sclerosis (MS) and Alzheimer's disease (AD) compared to healthy controls. METHODS: Seven databases (Medline, Embase, ScienceDirect, Web of Science, The Cochrane Library, Scielo and Lilacs) were searched between March 2020 and December 2022. Observational studies (i.e., cross-sectional, case-control, cohort) were included. GRADE approach was used to assess the quality of evidence and strength of the recommendation. Effect size was calculated using standardized mean differences (SMD; random effects model). A customized Downs and Black checklist was used to assess the risk of bias. RESULTS: Eighteen studies (PD = 7, MS = 11) were included. A total of 627 individuals with PD (healthy controls = 857) and 3923 individuals with MS (healthy controls = 2432) were analyzed. Twelve studies (PD = 4, MS = 8) were included in the meta-analysis. Individuals with PD had significantly elevated levels of depression (very low evidence, SMD = 0.40, p = 0.04) and stress (very low evidence, SMD = 0.60, p < 0.0001). There was no difference in anxiety (p = 0.08). Individuals with MS had significantly higher levels of depression (very low evidence, SMD = 0.73, p = 0.007) and stress (low evidence, SMD = 0.69, p = 0.03) and low quality of life (very low evidence, SMD = 0.77, p = 0.006). There was no difference in anxiety (p = 0.05) and sleep quality (p = 0.13). It was not possible to synthesize evidence in individuals with AD and sleep disorder (insomnia). CONCLUSION: In general, the COVID-19 pandemic negatively impacted individuals with PD and MS. Individuals with PD showed significantly higher levels of depression and stress; and individuals with MS presented significantly higher depression and stress levels, as well as significantly lower quality of life when compared to healthy controls. Further studies are needed to investigate the impact of the COVID-19 pandemic in individuals with AD.
Assuntos
COVID-19 , Doenças Desmielinizantes , Doença de Parkinson , Distúrbios do Início e da Manutenção do Sono , Transtornos do Sono-Vigília , Humanos , Pandemias , COVID-19/epidemiologia , Distúrbios do Início e da Manutenção do Sono/epidemiologia , Qualidade de Vida , Estudos Transversais , Transtornos do Sono-Vigília/epidemiologia , Doença de Parkinson/complicações , Doença de Parkinson/epidemiologia , Depressão/epidemiologiaRESUMO
OBJECTIVE: To determine the effectiveness of kinesiotaping (KT) with or without co-interventions for clinical outcomes in patients with subacromial impingement syndrome (SIS). DESIGN: Systematic review with meta-analysis of randomized clinical trials. DATA SOURCES: Eight databases (MEDLINE, CENTRAL, EMBASE, PEDro, LILACS, CINAHL, SPORTDiscus, and Web of Science) were searched from inception until March 2021. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Clinical trials that determine the effectiveness of KT with or without co-interventions for clinical outcomes in patients with SIS who are older than 18 years of age. RESULTS: Ten trials for the quantitative analysis were included. For pain intensity at 1-3 weeks, the overall pooled MD was -0.73 cm, 95% CI = -1.50 to 0.04 (p = 0.06), and at 3-6 weeks, it was -0.13 cm, 95% CI = -1.37 to 0.36 (p = 0.25). For shoulder function, the MD was -0.02, 95%CI = -0.30 to 0.26 (p = 0.89). For shoulder Range of Motion (ROM) flexion, the MD was -16.70, 95% CI = -0.52 to 33.92 (p = 0.06). Additionally, there was a low to moderate quality of evidence according to the GRADE rating. CONCLUSION: Kinesiotaping with or without co-interventions was not superior to other interventions for improving shoulder pain intensity, function and ROM flexion in patients with SIS.
Assuntos
Fita Atlética , Síndrome de Colisão do Ombro , Humanos , Medição da Dor , Amplitude de Movimento Articular , Síndrome de Colisão do Ombro/terapia , Dor de Ombro/terapiaRESUMO
Abstract Background: Fatigue is a disabling symptom in the spectrum of Parkinson's disease (PD), affecting from 30% to 70% of the persons. Even though it is a common symptom, with negative repercussions for PD individuals, its correlation with balance is not established. Aim: The aims of this study were to verify the correlation between fatigue and balance in individuals with PD and to compare balance in individuals with PD that presents low fatigue or high fatigue. Methods: This study included 37 individuals with PD, who were divided into two groups: low fatigue (n = 25) and high fatigue (n = 12). Fatigue was evaluated using the Parkinson's disease Fatigue Scale and a force platform was used to assess four balance tasks: bipedal, tandem with eyes open/closed, and tandem with the dual-task, in three parameters: (1) 95% confidence ellipse area of the center of pressure (COP) (2) mean velocity (3) root mean square of COP. To verify the correlation between fatigue and balance, the Spearman rank-order correlation coefficient was assessed. Comparison of medians between the groups was analyzed using the Mann-Whitney test. Results: There was no significant correlation between fatigue and balance. There was no difference between the groups with low and high fatigue. Conclusion: This study's findings, together with those reported in the literature, suggest there is no correlation between fatigue and balance, and even though individuals with PD report fatigue or experience situations of fatigue, they do not present greater posture instability than individuals with PD who do not report fatigue. Fatigue is a disabling symptom in the spectrum of Parkinson's disease (PD), affecting from
Assuntos
Humanos , Doença de Parkinson/diagnóstico , Equilíbrio Postural , Fadiga , Estudos Transversais/instrumentação , Estatísticas não ParamétricasRESUMO
OBJECTIVE: To provide reference values for functional fitness tests (PFFT) and verify the capability of these tests alone and grouped into a general index (GFFI-6), to predict mortality from all causes, during seven years of follow-up of physically independent older adults. METHODS: The sample consisted of 422 older adults, evaluated at baseline using six PFFTs, as well as sociodemographic, behavioral, anthropometric, and comorbidity variables. Mortality from all causes was followed for seven subsequent years. The sample was subdivided into four groups according to sex and age. Performances in the PFFT and GFFI-6 tests were ranked into "low", "regular", and "high". RESULTS: Cox proportional regression, with the adjustment of variables, indicated that the Unipedal Balance Test (BAL), Body Agility (AGI), Sit and Stand-up (SIT-SD) tests, and GFFI-6 were able to significantly predict mortality, indicating that older adults with "low" performance have, respectively, a 2.7 (CI=1.54-4.89, p = 0.01), 4.2 (CI=2.10-8.41), 2.5 (CI=1.44-4.65, p = 0.01), and 4.7 (CI=2.10-10.81, p<0.01) times higher risk of death, compared to older adults with "high" performance. CONCLUSION: BAL, AGI, and SIT-SD tests alone and tests grouped in the GFFI-6 were strong predictors of all-cause mortality in physically independent older adults.
Assuntos
Exercício Físico , Força Muscular , Idoso , Força da Mão , Humanos , Aptidão FísicaRESUMO
ABSTRACT Although patients with chronic obstructive pulmonary disease (COPD) benefit in many ways after participating in pulmonary rehabilitation programs, high dropout rates are still observed among participants. This study aims to analyze the adherence rate and perceived satisfaction in individuals with chronic obstructive pulmonary disease who underwent high-intensity physical training on land (LG) and in water (WG). This study is an additional analysis from a randomized controlled trial. In total, 36 subjects (51%) completed the intervention. All participants underwent six months of high-intensity endurance and strength training. Adherence was assessed by the proportion of patients who completed the training program. Perceived satisfaction was evaluated using a questionnaire composed of structured and semi-structured questions. The interviews were recorded, transcribed, and analyzed according to the criteria of our thematic analysis. The Shapiro-Wilk test was used to assess data normality, and dropout rates were compared using the chi-square test. Statistical significance was set at 5%. Regarding adherence, 59% of WG participants and 44% of LG participants completed the program, with no difference between the groups (p>0.05). Individuals from both groups were equally satisfied after six months of physical training (<90%); the therapist-patient relationship and treatment effectiveness being important factors for this perception. Qualitative analysis also showed that WG participants reported a more prominent improvement in their respiratory symptoms, leisure, sensation of pain, and sleep. In conclusion, patients with COPD were satisfied after six months of high-intensity physical training in water and on land, noting that water exercising promoted additional benefits compared to land exercising. There seems to be no superiority to any of the regimens (water or land) regarding the adherence to the training programs.
RESUMO Embora os pacientes com doença pulmonar obstrutiva crônica (DPOC) se beneficiem de muitas maneiras de programas de reabilitação pulmonar, ainda são observadas altas taxas de desistência entre os participantes. O objetivo deste estudo foi analisar a taxa de adesão e a percepção de satisfação de indivíduos com DPOC que realizaram treinamento físico de alta intensidade em solo (GS) e água (GA). Foram realizadas análises adicionais de um ensaio clínico randomizado. 36 indivíduos (51%) completaram a intervenção. Todos os participantes foram submetidos a seis meses de treinamento de força e resistência de alta intensidade. A adesão foi avaliada pela proporção de pacientes que completaram o programa de treinamento e a satisfação foi avaliada por meio de um questionário composto por questões estruturadas e semiestruturadas. As entrevistas foram gravadas, transcritas e analisadas de acordo com o critério de análise de conteúdo. Foi utilizado o teste de Shapiro-Wilk para avaliar a normalidade dos dados e o teste qui-quadrado para a comparação da taxa de aderência. Foi adotado p<0,05 como significância estatística. Em relação à adesão, 59% dos participantes do GA e 44% do GS completaram o programa, sem diferença entre os grupos (p>0,05). Os indivíduos de ambos os grupos estavam igualmente satisfeitos após seis meses de treinamento físico (<90%), sendo a relação terapeuta-paciente e a eficácia no tratamento fatores importantes para essa percepção. A análise qualitativa também mostrou que os participantes do GA relataram benefícios mais proeminentes em relação aos sintomas respiratórios, ao lazer, a sensação de dor e ao sono. Portanto, os pacientes com DPOC se mostraram satisfeitos após seis meses de treinamento e perceberam que o exercício na água promoveu mais benefícios do que em solo. Em relação à adesão aos programas de treinamento não pareceu haver superioridade de nenhum dos regimes (água ou solo).
RESUMEN Aunque los programas de rehabilitación pulmonar ayudan a los pacientes con enfermedad pulmonar obstructiva crónica (EPOC), todavía se observan altas tasas de abandono de los participantes en estos programas. El objetivo de este estudio fue evaluar la tasa de adherencia y la percepción de satisfacción de las personas con EPOC que realizaron entrenamiento físico de alta intensidad en suelo (GS) y en agua (GA). Se realizaron análisis adicionales de un ensayo clínico aleatorizado. 36 participantes (51%) completaron la intervención. Todos se sometieron a seis meses de entrenamiento de fuerza y resistencia de alta intensidad. La adherencia se evaluó por la proporción de pacientes que completaron el programa de entrenamiento, y la satisfacción se evaluó mediante un cuestionario con preguntas estructuradas y semiestructuradas. Las entrevistas fueron grabadas, después transcritas y analizadas según el criterio de análisis de contenido. Para evaluar la normalidad de los datos, se utilizó el test de Shapiro-Wilk, y para comparar la tasa de adherencia se aplicó la prueba de chi-cuadrado. El nivel de significación estadística fue de p<0,05. En cuanto a la adherencia, el 59% de los participantes del GA y el 44% del GS completaron el programa, sin diferencia entre grupos (p>0,05). Ambos grupos estaban igualmente satisfechos después de seis meses de entrenamiento físico (<90%), por lo que la relación terapeuta-paciente y la eficacia del tratamiento fueron los factores importantes de esta percepción. El análisis cualitativo también apuntó que los participantes de GA informaron más beneficios con respecto a los síntomas respiratorios, el ocio, la sensación de dolor y el sueño. Por lo tanto, los pacientes con EPOC estaban satisfechos después de seis meses de entrenamiento y se dieron cuenta de que el ejercicio en el agua les brindaba más beneficios que el ejercicio en el suelo. En cuanto a la adherencia al carácter de los programas de entrenamiento (si agua o suelo), no pareció haber superioridad en ninguno de ellos.
RESUMO
BACKGROUND: The relation between oxidative stress (OS) and sarcopenia in COPD remains unknown. OBJECTIVE: To analyze OS levels and its association with sarcopenia in COPD. METHODS: Thirty-nine individuals with COPD (69±7years; 41%female) and thirty-five for the control group (69±7years; 43%female) were included. Advanced oxidation protein products (AOPP), paraoxonase-1 (PON1), superoxide dismutase activity (SOD), catalase dismutase activity (CAT), sulfhydryl group (SH), nitric oxide metabolites (NOX), total radical trapping antioxidant parameter (TRAP) were analysed. OS markers were correlated with handgrip and quadriceps strength, gait speed, skeletal muscle mass index, fat-free mass index, maximum inspiratory and expiratory pressure. European criteria were used to identify sarcopenia. RESULTS: In COPD, antioxidant capacity was correlated with muscle mass and strength (r from 0.5 to 0.64) P<0.05 for all. TRAP≤ 850 µM/trolox and AOPP≤65 µM/l were associated with sarcopenia (OR:8.3; 95% CI: 1.4-49.6 and OR:14; 95%CI: 2.2-87.1, respectively; P<0.05 for both). CONCLUSION: OS is associated with sarcopenia in COPD.
Assuntos
Doença Pulmonar Obstrutiva Crônica , Sarcopenia , Idoso , Antioxidantes , Arildialquilfosfatase , Biomarcadores , Feminino , Força da Mão , Humanos , Masculino , Pessoa de Meia-Idade , Oxidantes , Doença Pulmonar Obstrutiva Crônica/complicações , Sarcopenia/diagnósticoRESUMO
BACKGROUND: Previous studies have reported that maximum voluntary ventilation (MVV) may be better associated with commonly used outcomes in COPD than FEV1 and may provide information on respiratory mechanics. In this study, we aimed to investigate the relationship between MVV and clinical outcomes in COPD and to verify whether MVV predicts these outcomes better than FEV1. METHODS: We conducted a cross-sectional study involving individuals with COPD. Lung function was assessed with spirometry; maximum inspiratory and expiratory pressures (PImax and PEmax, respectively) were assessed with manuvacuometry; and functional exercise capacity was assessed with the 6-min-walk test (6MWT). Dyspnea was assessed with the modified Medical Research Council (mMRC) scale; functional status was assessed with the modified Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ-m); and health status was assessed with the COPD Assessment Test (CAT). Correlations were verified with the Spearman coefficient, and stepwise multiple linear regression models investigated the predictors of clinical outcomes. RESULTS: Our study included 157 subjects: 82 males; median (interquartile range) age 66 (61-73) y; FEV1 46 (33-57) % predicted; 6MWT 86 (76-96) % predicted; PFSDQ-m total score 34 (14-57); and CAT total score 13 (7-19). Moderate correlations were found between MVV and PImax (r = 0.40), 6MWT (r = 0.50), mMRC (r = -0.56), and total scores on the PFSDQ-m (r = -0.40) and the CAT (r = -0.54). In the regression models, MVV was a predictor of almost all clinical outcomes, unlike FEV1. CONCLUSIONS: MVV correlates moderately with clinical outcomes commonly used in the evaluation of individuals with COPD, and MVV is a better predictor of respiratory muscle strength, functional exercise capacity, and patient-reported outcomes than FEV1.
Assuntos
Doença Pulmonar Obstrutiva Crônica , Estudos Transversais , Volume Expiratório Forçado , Humanos , Ventilação Voluntária Máxima , Doença Pulmonar Obstrutiva Crônica/terapia , EspirometriaRESUMO
INTRODUCTION: The perception of health professionals about chronic obstructive pulmonary disease (COPD) has not been thoroughly investigated. OBJECTIVE: To analyze the perception of health professionals about the impact of COPD on the lives of affected individuals. MATERIALS AND METHODS: Qualitative and cross-sectional study with five health professionals: two nurses, two physiotherapists, and one medical doctor. They participated in a focus group (FG) session, with semistructured questions covering: definition of COPD, activities of daily living (ADL), and physical activity of daily living (PADL), as well as the importance of these outcomes in the lives of individuals with COPD. DATA ANALYSIS: The FG was recorded, transcribed, and analyzed according to the content analysis. RESULTS: The FG highlighted four main themes: physical-functional and emotional impairment of individuals, the importance of patient-health professional contact, repercussions of COPD on the patients' physical activity, and strategies for promoting physical activity. Based on the four themes exposed, the health professionals reported that there is a progression in the lives of individuals' with COPD, which is divided into three phases: adaptation, reluctance, and dependence. CONCLUSION: There was a negative perception of the health professionals regarding the functionality and emotion of patients with COPD. Emotional aspects, family support, and architectural structure can positively or negatively influence patients' ADL and PADL. Finally, there was a perception of progression in the life of patients with COPD, since their initial adaptation, evolving to physical and emotional dependence.
Assuntos
Atividades Cotidianas , Doença Pulmonar Obstrutiva Crônica , Estudos Transversais , Humanos , Percepção , Qualidade de Vida , AutocuidadoRESUMO
La sarcopenia es uno de los principales síndromes geriátricos que está asociada con limitación en las actividades de la vida diaria, discapacidad y mortalidad en la población adulta mayor. Sin embargo, su definición, criterios diagnósticos y puntos de corte son diversos en la literatura, lo que dificulta el diagnóstico de la sarcopenia. El objetivo de esta revisión narrativa fue detectar en la literatura todos los consensos internacionales relacionados con sarcopenia, comparar su definición, criterios diagnósticos y puntos de corte, con el propósito de identificar una definición y criterios que puedan ser utilizados en Latinoamérica. Fueron identificados 7 consensos internacionales que han definido la sarcopenia como un síndrome/enfermedad caracterizado por la pérdida de la masa y función muscular asociada al proceso de envejecimiento. A pesar de tener una definición similar, no hay una total concordancia entre los criterios y evaluaciones. La sarcopenia puede ser detectada utilizando evaluaciones funcionales de fuerza muscular, velocidad de la marcha y equilibrio, que son frecuentemente utilizados por profesionales del área de la rehabilitación. Adicionalmente, el riesgo de sarcopenia puede ser identificado utilizando los cuestionarios SARC-F y SARC-CalF. Debido a su impacto funcional, la sarcopenia debería ser diagnosticada precozmente en adultos mayores por terapeutas ocupacionales, kinesiólogos y fisioterapeutas, para prevenir y tratar futuras complicaciones clínicas y funcionales en esta población. Es necesario la creación de valores de referencia para favorecer el diagnóstico de la sarcopenia en población latinoamericana.
Sarcopenia is one of the main geriatric syndromes that has been associated with limitation in activities of daily living, disability, and mortality in the elderly population. However, the definition, diagnostic criteria and cut-off points are diverse in the literature, which makes the diagnosis of sarcopenia difficult. The aim of this narrative review was to detect in the literature all the international consensus related to sarcopenia, to compare their definition, diagnostic criteria and cut-off points, in order to identify a definition and criteria that can be used in Latin America. Seven international consensuses were identified that have defined sarcopenia as a syndrome / disease characterized by loss of muscle mass and function associated with the aging process. Despite having a similar definition, there is not a total concordance between the criteria and evaluations. Sarcopenia can be detected using functional assessments of muscle strength, gait speed, and balance, which are frequently used by professionals in the area of rehabilitation. Additionally, the risk of sarcopenia can be assessed using SARC-F and SARC-CaF. Due to its functional impact, sarcopenia should be diagnosed early in older adults by occupational therapists, physical therapists and physiotherapists, to prevent and treat future clinical and functional complications in this population. The creation of reference values is necessary to favor the diagnosis of sarcopenia in the Latin American population.
Assuntos
Humanos , Idoso , Envelhecimento , Sarcopenia/diagnóstico , Valores de Referência , Prevalência , Terapia Ocupacional , Força Muscular , Sarcopenia/etiologia , Sarcopenia/epidemiologia , América LatinaRESUMO
Social participation is defined as the integration of people into community activities in voluntary or mandatory, formal and informal social groups, which could have consequences concerning the health of the older population. A search was conducted on Pubmed, Scielo, Scopus and Google Scholar. For this review, 16 articles studying the impact of social participation on older adults were analyzed, including a total of 73,698,096 individuals from North America, Asia, Europe, and Latin America. Social participation is considered a protective factor for the mental and physical health of older adults, which has been associated with decreases in disability, co-morbidities, and mortality. For this reason, it is suggested that it should be evaluated in clinical practice. This would make it possible to orient and refer older adults to participate in certain community organizations, mainly those who do not have support networks, who are not linked to community groups, who have symptoms of depression or who are beginning to show physical or cognitive deterioration. In this way, public health could increase its prevention and health promotion actions through community organizations. On the other hand, the lack of instruments and consensus to evaluate social participation was discussed in this review where a questionnaire to evaluate the social participation of the older adult has been proposed to be validated and studied in the future.
La participación social es definida como la integración de las personas a actividades de la comunidad en grupos sociales voluntarios u obligatorios, formales e informales, lo cual podría tener consecuencias en la salud de la población adulta mayor. Fue realizada una búsqueda en Pubmed, Scielo, Scopus y Google Scholar. Para esta revisión se analizaron 16 artículos que estudiaban el impacto de la participación social en adultos mayores, incluyendo un total de 73 698 096 individuos de Norteamérica, Asia, Europa, y América latina. La participación social es considerada como un factor protector para la salud mental y física de los adultos mayores, la cual ha sido asociada a disminuciones de la discapacidad, comorbilidades y mortalidad. Por esta razón, se sugiere que debe ser evaluada en la práctica clínica. Esto permitiría orientar y derivar a los adultos mayores a participar de determinadas organizaciones comunitarias, principalmente aquellos que no tienen redes de apoyo, que no están vinculados a grupos comunitarios, que tienen síntomas de depresión o que están iniciando un cuadro de deterioro físico o cognitivo. De este modo, la salud pública podría aumentar sus acciones de prevención y promoción de la salud por medio de las organizaciones comunitarias. Por otro lado, la falta de instrumentos y consensos para evaluar la participación social fue discutida en esta revisión donde se ha propuesto un cuestionario de evaluación de la participación social del adulto mayor que debe ser validado y estudiado en el futuro.
Assuntos
Avaliação Geriátrica , Participação Social , Idoso , HumanosRESUMO
Sarcopenia prevalence and its clinical impact are reportedly variable in chronic obstructive pulmonary disease (COPD) due partly to definition criteria. This review aimed to identify the criteria used to diagnose sarcopenia and the prevalence and impact of sarcopenia on health outcomes in people with COPD. This review was registered in PROSPERO (CRD42018092576). Five electronic databases were searched to August 2018 to identify studies related to sarcopenia and COPD. Study quality was assessed using validated instruments matched to study designs. Sarcopenia prevalence was determined using authors' definitions. Comparisons were made between people who did and did not have sarcopenia for pulmonary function, exercise capacity, quality of life, muscle strength, gait speed, physical activity levels, inflammation/oxidative stress, and mortality. Twenty-three studies (70% cross-sectional) from Europe (10), Asia (9), and North and South America (4) involving 9637 participants aged ≥40 years were included (69.5% men). Sarcopenia criteria were typically concordant with recommendations of hEuropean and Asian consensus bodies. Overall sarcopenia prevalence varied from 15.5% [95% confidence interval (CI) 11.8-19.1; combined muscle mass, strength, and/or physical performance criteria] to 34% (95%CI 20.6-47.3; muscle mass criteria alone) (P = 0.009 between subgroups) and was greater in people with more severe [37.6% (95%CI 24.8-50.4)] versus less severe [19.1% (95%CI 10.2-28.0)] lung disease (P = 0.020), but similar between men [41.0% (95%CI 26.2-55.9%)] and women [31.9% (95%CI 7.0-56.8%)] (P = 0.538). People with sarcopenia had lower predicted forced expiratory volume in the first second (mean difference -7.1%; 95%CI -9.0 to -5.1%) and poorer exercise tolerance (standardized mean difference -0.8; 95%CI -1.4 to -0.2) and quality of life (standardized mean difference 0.26; 95%CI 0.2-0.4) compared with those who did not (P < 0.001 for all). No clear relationship was observed between sarcopenia and inflammatory or oxidative stress biomarkers. Incident mortality was unreported in the literature. Sarcopenia is prevalent in a significant proportion of people with COPD and negatively impacts upon important clinical outcomes. Opportunities exist to optimize its early detection and management and to evaluate its impact on mortality in this patient group.
Assuntos
Doença Pulmonar Obstrutiva Crônica , Sarcopenia , Estudos Transversais , Feminino , Força da Mão , Humanos , Masculino , Prevalência , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Qualidade de Vida , Sarcopenia/diagnóstico , Sarcopenia/epidemiologia , Sarcopenia/etiologiaRESUMO
RESUMEN La participación social es definida como la integración de las personas a actividades de la comunidad en grupos sociales voluntarios u obligatorios, formales e informales, lo cual podría tener consecuencias en la salud de la población adulta mayor. Fue realizada una búsqueda en Pubmed, Scielo, Scopus y Google Scholar. Para esta revisión se analizaron 16 artículos que estudiaban el impacto de la participación social en adultos mayores, incluyendo un total de 73 698 096 individuos de Norteamérica, Asia, Europa, y América latina. La participación social es considerada como un factor protector para la salud mental y física de los adultos mayores, la cual ha sido asociada a disminuciones de la discapacidad, comorbilidades y mortalidad. Por esta razón, se sugiere que debe ser evaluada en la práctica clínica. Esto permitiría orientar y derivar a los adultos mayores a participar de determinadas organizaciones comunitarias, principalmente aquellos que no tienen redes de apoyo, que no están vinculados a grupos comunitarios, que tienen síntomas de depresión o que están iniciando un cuadro de deterioro físico o cognitivo. De este modo, la salud pública podría aumentar sus acciones de prevención y promoción de la salud por medio de las organizaciones comunitarias. Por otro lado, la falta de instrumentos y consensos para evaluar la participación social fue discutida en esta revisión donde se ha propuesto un cuestionario de evaluación de la participación social del adulto mayor que debe ser validado y estudiado en el futuro.
ABSTRACT Social participation is defined as the integration of people into community activities in voluntary or mandatory, formal and informal social groups, which could have consequences concerning the health of the older population. A search was conducted on Pubmed, Scielo, Scopus and Google Scholar. For this review, 16 articles studying the impact of social participation on older adults were analyzed, including a total of 73,698,096 individuals from North America, Asia, Europe, and Latin America. Social participation is considered a protective factor for the mental and physical health of older adults, which has been associated with decreases in disability, co-morbidities, and mortality. For this reason, it is suggested that it should be evaluated in clinical practice. This would make it possible to orient and refer older adults to participate in certain community organizations, mainly those who do not have support networks, who are not linked to community groups, who have symptoms of depression or who are beginning to show physical or cognitive deterioration. In this way, public health could increase its prevention and health promotion actions through community organizations. On the other hand, the lack of instruments and consensus to evaluate social participation was discussed in this review where a questionnaire to evaluate the social participation of the older adult has been proposed to be validated and studied in the future.
Assuntos
Idoso , Humanos , Avaliação Geriátrica , Participação SocialRESUMO
BACKGROUND: The relation between mechanical ventilation (MV) and bronchopulmonary dysplasia (BPD) - a common disease in extremely premature newborn (PTNB) - is well stabilished, but is unknown, however, how much time under MV influences the severity of the disease. AIM: To define the duration under MV with greater chance to develop moderate to severe BPD in extremely PTNB and to compare clinical outcomes before and during hospitalization among patients with mild and moderate to severe BPD. METHODS: Fifty-three PTNB were separated into mild and moderate to severe BPD groups and their data were analyzed. Time under MV with a greater chance of developing moderate to severe BPD was estimated by the ROC curve. Perinatal and hospitalization outcomes were compared between groups. A logistic regression was performed to verify the influence of variables associated to moderate to severe BPD development, such as pulmonary hypertension (PH), gender, gestational age (GA) and weight at birth, as well the time under MV found with ROC curve. The result of ROC curve was validated using an independent sample (n = 16) by Chi-square test. RESULTS: Time under MV related to a greater chance of developing moderate to severe BPD was 36 days. Moderate to severe BPD group had more males (14 vs 5, p = 0,047), longer time under MV (43 vs 19 days, p < 0,001), more individuals with PH (12 vs 3, p = 0,016), worse retinopathy of prematurity (grade 3, 2 vs 11, p = 0,003), longer hospital length of stay (109 vs 81,5 days, p < 0,001), greater PMA (41 vs 38 weeks, p < 0,001) and weight (2620 vs 2031 g, p < 0,001) at discharge and the mild BPD group had more CPAP use prior to MV (12 vs 7, p = 0,043). Among all variables included in logistic regression, only PH and MV < 36 days were significant in the model, explaining 72% of variation in moderate to severe BPD development. In the validation sample, prevalence of preterm infants who needed MV for more than 36 days in the moderate to severe BPD group was 100% (n = 6) and 0% in mild BPD group (p = 0,0001). CONCLUSION: Time under MV related to moderate to severe BPD development is 36 days, and worst outcomes are related to disease severity. PH and time under MV for more than 36 days are related to development of moderate to severe BPD.
Assuntos
Displasia Broncopulmonar , Displasia Broncopulmonar/epidemiologia , Feminino , Idade Gestacional , Humanos , Lactente , Lactente Extremamente Prematuro , Recém-Nascido , Masculino , Projetos Piloto , Gravidez , Respiração ArtificialRESUMO
Resumen Introducción: el envejecimiento se caracteriza por cambios fisiológicos, entre ellos un aumento del estrés oxidativo (EO), que es un factor de riesgo para el desarrollo de múltiples patologías. La actividad física en la vida diaria (AFVD) es un factor protector para la salud y podría estar asociado con una disminución del EO. Objetivo: analizar la correlación entre AFVD y los biomarcadores de EO en adultos mayores. Materiales y Métodos: se incluyeron 35 adultos mayores (edad: 69 ± 7 años, hombres: 57%). La actividad física fue evaluada utilizando el acelerómetro triaxial DynaPort, que midió el tiempo en 6 actividades: Caminata rápida, acostado, sentado, de pie, en movimiento y caminata lenta, respectivamente. Fueron evaluados los siguientes biomarcadores de sangre periférica: Productos avanzados de oxidación de proteínas (AOPP), óxido nítrico (NOx), capacidad antioxidante total (TRAP), grupo de sulfhidrilo (SH) y enzima superóxido dismutasa (SOD). Además, el nivel glicémico, IMC y circunferencia abdominal. Los coeficientes de correlación de Pearson o Spearman fueron utilizados respectivamente, con p < 0.05 e IC: 95%. Resultados: SOD tuvo una correlación con tiempos de caminata rápida (r = 0.6) y de movimiento (r = 0.6). AOPP tuvo una correlación con los tiempos de caminata rápida (r = -0.4), caminata lenta (r = -0.5), de pie (r = -0.4), en movimiento (r = -0.4) y acostado (r = 0.5). El IMC tuvo una correlación con el tiempo en movimiento (r = -0.4). La glucosa fue correlacionada con el tiempo de caminata rápida (-r = 0.63), de pie (r = -0.5), en movimiento (r = -0.6), caminata lenta (r = -0.61) y acostado (r = 0.54). Conclusiones: niveles aumentados de actividad física de la vida diaria están asociados con mayor capacidad antioxidante, menor estrés oxidativo, nivel glicémico e IMC. MÉD.UIS.2020;33(1): 13-9.
Abstract Introduction: aging is characterized by physiological changes, including increased oxidative stress (OS), which is a risk factor for the development of multiple pathologies. Physical activity in daily life (PADL) is a protective factor for health and could be associated with a decrease in oxidative stress. Objective: to analyze the correlation of PADL and blood biomarkers of OS in older adults. Materials and Method: 35 older adults were included (age: 69 ± 7 years, men: 57%). PADL was objectively evaluated using the DynaPort triaxial accelerometer, which measured the time in 6 different activities: Fast walking, lying, sitting, standing, moving and slow walking, respectively. The following biomarkers from peripheral blood were measured: advanced protein oxidation products (AOPP), nitric oxide (NOx), total antioxidant potential (TRAP), sulfhydryl group (SH) and superoxide enzyme dismutase (SOD). Blood glucose level, BMI and abdominal girth also were considered. The Pearson or Spearman correlation coefficients were used respectively, with p < 0.05 and 95% CI. Results: SOD had a correlation with fast walking (r = 0.6) and moving time (r = 0.6). AOPP had a correlation with fast walking (r = -0.4), slow walking (r = -0.5), standing (r = -0.4), moving (r = -0.4) and the lying time (r = 0.5). BMI had a correlation with moving time (r = -0.4). Glucose had a correlation with fast walking (-r = 0.63), standing (r = -0.5), moving (r = -0.6), slow walking (r = -0.61) and lying time (r = 0.54). Conclusions: increased levels of physical activity in daily life are significantly associated with greater antioxidant capacity, lower oxidative stress, glucose and BMI. MÉD.UIS.2020;33(1): 13-9.